Abstract
In December, the Substance Abuse and Mental Health Services Administration (SAMHSA) released a notice of proposed rulemaking (NPRM) that would make permanent the take‐home exemptions for methadone under which, due to COVID‐19, it was possible for “less stable” patients to receive more take‐homes (https://onlinelibrary.wiley.com/doi/10.1002/adaw.33643). In addition, the proposal would remove the one‐year requirement for opioid use disorder (OUD), remove the reliance on toxicology tests and the length of time in treatment, and allow telehealth inductions by methadone.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
